ROBERT SIMON: Open Payments
NPI 1629421664 · KINGWOOD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,171 in 57 payments from 13 companies in 2025. Trend: 2023 $824 · 2024 $971 · 2025 $1,171
Food & beverage: $1,171
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 13 | $252 |
| Neurocrine BioSciences, Inc. | 9 | $238 |
| Lundbeck LLC | 10 | $201 |
| Otsuka America Pharmaceutical, Inc. | 10 | $138 |
| E.R. Squibb & Sons, L.L.C. | 3 | $66 |
| Janssen Pharmaceuticals, Inc | 2 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $48 |
| ABBVIE INC. | 2 | $46 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Corium, LLC | 1 | $27 |
Products named: REXULTI, LYBALVI, INGREZZA, COBENFY, SPRAVATO, CAPLYTA, VRAYLAR, Auvelity.
Industry payments across TX — which companies pay providers there.
